Zobrazeno 1 - 10
of 51
pro vyhledávání: '"G L, Grunkemeier"'
Autor:
Ruediger Lange, Michael Wottke, G L Grunkemeier, S Kaempchen, Michael A. Toschke, Thomas Guenther
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 23:710-714
Objective: The standard method of analysing structural valve degeneration (SVD) of biological prostheses is the Kaplan‐ Meier method. In order to assess SVD with regard to competing risks (e.g. death particularly in elderly patients) cumulative inc
Autor:
G L, Grunkemeier, Y, Wu
Publikováno v:
The Journal of heart valve disease. 10(4)
Publikováno v:
The Journal of heart valve disease. 8(5)
Having performed our first heart valve replacement in 1960, we began a prospective lifetime follow up service for all patients, contacting them at least annually to determine survivorship and heart valve complications.We reviewed isolated aortic (AVR
Autor:
W. R. E. Jamieson, Robert T. Miyagishima, Eva Germann, Lawrence H. Burr, Guy Fradet, Charmaine Henderson, Samuel V. Lichtenstein, G. L. Grunkemeier
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 15(6)
Objective: The experience with the Carbomedics (CM) and the St. Jude Medical (SJM) bileaflet mechanical prostheses was evaluated to determine thromboembolic and hemorrhagic complications and predictive risk factors. Methods: From 1989 to 1994, a tota
Publikováno v:
The Journal of heart valve disease. 8(2)
This article presents the protocol of the Artificial Valve Endocarditis Reduction Trial (AVERT), a multicenter, international randomized trial to assess the efficacy of the SilzoneTM coating of St. Jude Medical Masters Series mechanical heart valves
Autor:
W R, Jamieson, R T, Miyagishima, G L, Grunkemeier, E, Germann, C, Henderson, S V, Lichtenstein, H, Ling, A I, Munro
Publikováno v:
Canadian journal of surgery. Journal canadien de chirurgie. 42(1)
To determine major thromboembolic and hemorrhagic complications and predictive risk factors associated with aortic valve replacement (AVR), using bileaflet mechanical prostheses (CarboMedics and St. Jude Medical).A case series.Cardiac surgical servic
Autor:
G L, Grunkemeier, W N, Anderson
Publikováno v:
The Journal of heart valve disease. 7(2)
We discuss the clinical assessment of heart valve substitutes, primarily with regard to pre-market evaluation. We concentrate on the current FDA heart valve guidance document. This guidance is self-acknowledged to be an evolving document, scheduled t
Publikováno v:
The Journal of heart valve disease. 6(5)
Prosthetic valve endocarditis (PVE) emerged approximately 37 years ago when the first human heart valve replacements were performed. PVE can be classified as 'early' or 'late' with the pathophysiology and etiologic organisms varying between the two s
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 112(3)
Publikováno v:
The Annals of thoracic surgery. 62(3)
At the request of the Councils of The Society of Thoracic Surgeons (STS) and The American Association for Thoracic Surgery (AATS) the Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity "revisited" the "Guidelin